FDA Approves Lipfendra: A Game-Changer in Cholesterol Treatment
Understanding the Taylor Farms Cyclospora False Positive and Recall
The Hidden Link Between Heart Health and Vision Loss in Latino Adults
Could AI Explain the Fermi Paradox? Exploring Quiet Expansion in Space
What's New?
High-Functioning Burnout: Why Moms Are Most at Risk
June 17, 2026
Portable EKG Devices Reshaping At-Home Heart Monitoring
June 17, 2026
ADHD Masking Harms Mental Health Despite Social Benefits
June 15, 2026
Must Reads
More on medicalnewsalley
Understanding the Impact of Trauma on Criminal Behavior
February 28, 2025
Individuals with a history of trauma are significantly overrepresented in the criminal justice system, and understanding how trauma affects brain development, emotional regulation, and behavior is key to developing more effective approaches to crime prevention and rehabilitation.
The Growing Need for Accessible Mental Health Resources
February 28, 2025
Mental health awareness has grown, but access to proper care remains a significant challenge due to high costs, provider shortages, and stigma. This article explores the barriers to mental health resources and the role of counselors, technology, community programs, and education in expanding access to care.
Transform Patient Care: Design an Intuitive EHR Software with Customizable Templates and Secure Data Management
February 27, 2025
Electronic Health Record (EHR) software has transformed healthcare by replacing paper records with digital solutions, but an effective EHR must be intuitive, customizable, and secure to truly enhance patient care.
Clade 2.3.4.4b H5N1 Bovine flu vaccine on the way say US scientists
January 30, 2025
The battle continues against H5N1 flu in North America, but followers of the news will be reassured to hear that a cutting edge H5N1 vaccine for the highly virulent strain currently spreading in cows is in the works. Since seasonal flu vaccines do not protect against H5N1 flu, vaccine scientists have been racing against the […]
Update: Lipoprotein (a) drug, Muvalaplin, clears phase II clinical trials
January 27, 2025
Muvalaplin, a drug targeting lipoprotein (a), has successfully passed phase II clinical trials, demonstrating reductions of up to 85.7% in lipoprotein (a) levels over twelve weeks with a favorable safety profile comparable to placebo.
Pain coping techniques take the sting out of life for dialysis patients
January 24, 2025
A new clinical study shows that Pain Coping Skills Training (PCST), a cognitive behavioural therapy-based approach, significantly reduced pain interference in daily activities for dialysis patients, offering a promising non-drug alternative to traditional pain management.
Key Performance Indicators for Payor Enrollment Success: A Data-Driven Analysis
January 23, 2025
An analysis of key performance indicators for payor enrollment success, offering data-driven metrics, practical tracking strategies, and actionable tips to help healthcare organizations reduce delays and improve enrollment efficiency.